ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

NCAB Oks LANs To Links NCI Staff With Each Other, The World

February 14, 1992

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Edelson To Step Down As Yale Center Director.

January 11, 2008

Funding Opportunities

September 20, 2002

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009